Zurcher Kantonalbank Zurich Cantonalbank Has $223,000 Position in Balchem Co. (NASDAQ:BCPC)

Share on StockTwits

Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Balchem Co. (NASDAQ:BCPC) by 23.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,233 shares of the basic materials company’s stock after buying an additional 430 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Balchem were worth $223,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. First National Bank of Omaha grew its position in Balchem by 0.7% during the first quarter. First National Bank of Omaha now owns 17,272 shares of the basic materials company’s stock worth $1,603,000 after buying an additional 124 shares in the last quarter. Arizona State Retirement System grew its position in Balchem by 0.3% during the first quarter. Arizona State Retirement System now owns 49,787 shares of the basic materials company’s stock worth $4,620,000 after buying an additional 125 shares in the last quarter. State of Alaska Department of Revenue grew its position in Balchem by 1.3% during the second quarter. State of Alaska Department of Revenue now owns 11,007 shares of the basic materials company’s stock worth $1,100,000 after buying an additional 143 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its position in Balchem by 3.7% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,714 shares of the basic materials company’s stock worth $437,000 after buying an additional 169 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC grew its position in Balchem by 1.8% during the first quarter. O Shaughnessy Asset Management LLC now owns 10,557 shares of the basic materials company’s stock worth $976,000 after buying an additional 188 shares in the last quarter. 86.16% of the stock is currently owned by institutional investors and hedge funds.

Shares of BCPC stock traded down $0.68 during trading hours on Tuesday, reaching $89.09. The company’s stock had a trading volume of 3,013 shares, compared to its average volume of 115,406. The firm’s 50 day simple moving average is $95.14 and its 200-day simple moving average is $94.17. The company has a market capitalization of $2.88 billion, a price-to-earnings ratio of 29.63 and a beta of 1.12. Balchem Co. has a fifty-two week low of $73.16 and a fifty-two week high of $117.79. The company has a quick ratio of 2.63, a current ratio of 3.73 and a debt-to-equity ratio of 0.33.

Balchem (NASDAQ:BCPC) last issued its earnings results on Thursday, August 1st. The basic materials company reported $0.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.08. The firm had revenue of $161.60 million for the quarter, compared to the consensus estimate of $163.14 million. Balchem had a return on equity of 13.87% and a net margin of 12.27%. The company’s revenue was down 1.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.76 EPS. Sell-side analysts predict that Balchem Co. will post 2.96 earnings per share for the current year.

In other Balchem news, VP Scott C. Mason bought 3,000 shares of Balchem stock in a transaction on Monday, August 5th. The shares were purchased at an average price of $84.74 per share, with a total value of $254,220.00. Following the acquisition, the vice president now owns 12,524 shares in the company, valued at approximately $1,061,283.76. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.28% of the company’s stock.

A number of equities research analysts have weighed in on BCPC shares. Pivotal Research downgraded Balchem from a “buy” rating to a “hold” rating and set a $100.00 target price on the stock. in a report on Monday, May 6th. BidaskClub downgraded Balchem from a “buy” rating to a “hold” rating in a report on Thursday, May 23rd. HC Wainwright reaffirmed a “buy” rating and issued a $95.00 target price (down previously from $110.00) on shares of Balchem in a report on Monday, August 5th. Finally, Zacks Investment Research downgraded Balchem from a “hold” rating to a “sell” rating in a report on Monday, August 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Balchem has an average rating of “Hold” and a consensus price target of $108.75.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Featured Story: How can investors find ex-dividend dates?

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.